I highly recommend it to anyone looking to improve gut health and lose weight.
Of the five trials that included PPS and placebo arms, four were RCTs
Private Plan Outlook Alberta Blue Cross's 2026 drug pipeline report identifies GLP-1 therapies as a major cost driver, stating that while a semaglutide generic is expected in mid-2026, overall GLP-1 therapy plan spend is unlikely to decline in future years due to growing use and continued expansion of GLP-1 therapies
Pinealon is sensitive to heat, light, and repeated freeze-thaw cycles
For these reasons, peptides should always be used under the supervision of a qualified physician who can evaluate medical history, order appropriate labs, discuss realistic expectations, and monitor for benefits and adverse effects
J Inherit.Metab Dis 2007;30(3):341-349